Related references
Note: Only part of the references are listed.A method to produce fully characterized ubiquitin covalently modified by 4-hydroxy-nonenal, glyoxal, methylglyoxal, and malondialdehyde
Mara Colzani et al.
FREE RADICAL RESEARCH (2016)
Molecular Mechanisms of Aldehyde Toxicity: A Chemical Perspective
Richard M. LoPachin et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2014)
Novel molecular approaches for improving enzymatic and nonenzymatic detoxification of 4-hydroxynonenal: toward the discovery of a novel class of bioactive compounds
Giancarlo Aldini et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
A novel high resolution MS approach for the screening of 4-hydroxy-trans-2-nonenal sequestering agents
Mara Colzani et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2014)
4-Hydroxy-2-Nonenal Enhances Tissue Factor Activity in Human Monocytic Cells via p38 Mitogen-Activated Protein Kinase Activation-Dependent Phosphatidylserine Exposure
Rit Vatsyayan et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Lipid peroxidation triggers neurodegeneration: A redox proteomics view into the Alzheimer disease brain
Rukhsana Sultana et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products
Giancarlo Aldini et al.
FREE RADICAL RESEARCH (2013)
Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation
G. Vistoli et al.
FREE RADICAL RESEARCH (2013)
Role of Aldose Reductase in the Metabolism and Detoxification of Carnosine-Acrolein Conjugates
Shahid P. Baba et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Apolipoprotein A-I: Insights from redox proteomics for its role in neurodegeneration
Jeriel T. R. Keeney et al.
PROTEOMICS CLINICAL APPLICATIONS (2013)
Transforming dietary peptides in promising lead compounds: the case of bioavailable carnosine analogs
Giulio Vistoli et al.
AMINO ACIDS (2012)
An update on advanced glycation endproducts and atherosclerosis
Serena Del Turco et al.
BIOFACTORS (2012)
Advanced Glycation End Products and Diabetic Cardiovascular Disease
Anand Prasad et al.
CARDIOLOGY IN REVIEW (2012)
Reactions of aminoguanidine with α-dicarbonyl compounds studied by electrospray ionization mass spectrometry
Marco A. Saraiva et al.
EUROPEAN JOURNAL OF MASS SPECTROMETRY (2012)
Phenol Group in Pyridoxamine Acts as a Stabilizing Element for Its Carbinolamines and Schiff Bases
Catalina Caldes et al.
CHEMISTRY & BIODIVERSITY (2011)
Design, Synthesis, ADME Properties, and Pharmacological Activities of β-Alanyl-D-histidine (D-Carnosine) Prodrugs with Improved Bioavailability
Marica Orioli et al.
CHEMMEDCHEM (2011)
The carbonyl scavenger carnosine ameliorates dyslipidaemia and renal function in Zucker obese rats
Giancarlo Aldini et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Water-Soluble α,β-Unsaturated Aldehydes of Cigarette Smoke Induce Carbonylation of Human Serum Albumin
Graziano Colombo et al.
ANTIOXIDANTS & REDOX SIGNALING (2010)
Carbonylation of myosin heavy chains in rat heart during diabetes
Chun-Hong Shao et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Involvement of the Toxic AGEs (TAGE)-RAGE System in the Pathogenesis of Diabetic Vascular Complications: A Novel Therapeutic Strategy
Masayoshi Takeuchi et al.
CURRENT DRUG TARGETS (2010)
Cytoprotective mechanisms of carbonyl scavenging drugs in isolated rat hepatocytes
Rhea Mehta et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2009)
Interferences and contaminants encountered in modern mass spectrometry
Bernd O. Keller et al.
ANALYTICA CHIMICA ACTA (2008)
Pyridoxamine protects proteins from functional damage by 3-deoxyglucosone: Mechanism of action of pyridoxamine
Sergei V. Chetyrkin et al.
BIOCHEMISTRY (2008)
HNE Michael adducts to histidine and histidine-containing peptides as biomarkers of lipid-derived carbonyl stress in urines: LC-MS/NIS profiling in Zucker obese rats
Marica Oriolli et al.
ANALYTICAL CHEMISTRY (2007)
Intervention strategies to inhibit protein carbonylation by lipoxidation-derived reactive carbonyls
Giancarlo Aldini et al.
MEDICINAL RESEARCH REVIEWS (2007)
Carbonylation of adipose proteins in obesity and insulin resistance - Identification of adipocyte fatty acid-binding protein as a cellular target of 4-hydroxynonenal
Paul A. Grimsrud et al.
MOLECULAR & CELLULAR PROTEOMICS (2007)
Advanced glycation end products - Sparking the development of diabetic vascular injury
Alison Goldin et al.
CIRCULATION (2006)
Protein carbonylation, cellular dysfunction, and disease progression
Isabella Dalle-Donne et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2006)
Selectivity descriptors for the Michael addition reaction as obtained from density functional based approaches
G Madjarova et al.
JOURNAL OF PHYSICAL CHEMISTRY A (2005)
Protein adduct-trapping by hydrazinophthalazine drugs: Mechanisms of cytoprotection against acrolein-mediated toxicity
PC Burcham et al.
MOLECULAR PHARMACOLOGY (2004)
Protein carbonyl groups as biomarkers of oxidative stress
I Dalle-Donne et al.
CLINICA CHIMICA ACTA (2003)
Carnosine is a quencher of 4-hydroxy-nonenal: through what mechanism of reaction?
G Aldini et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Effect of pyridoxamine on chemical modification of proteins by carbonyls in diabetic rats: characterization of a major product from the reaction of pyridoxamine and methylglyoxal
RH Nagaraj et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2002)
Identification of α-dicarbonyl scavengers for cellular protection against carbonyl stress
GT Wondrak et al.
BIOCHEMICAL PHARMACOLOGY (2002)
A post-amadori inhibitor pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation
PA Voziyan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Congeners of Nα-acetyl-L-cysteine, but not aminoguanidine act as neuroprotectants from the lipid peroxidation product 4-hydroxy-2-nonenal
MD Neely et al.
FREE RADICAL BIOLOGY AND MEDICINE (2000)
Kinetics and mechanism of the reaction of aminoguanidine with the α-oxoaldehydes glyoxal, methylglyoxal, and 3-deoxyglucosone under physiological conditions
PJ Thornalley et al.
BIOCHEMICAL PHARMACOLOGY (2000)